Prognosis Analysis of Elderly Donor Liver in Liver Transplantation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

11569 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-01

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Based on the follow-up data of elderly donation after cardiac death(DCD) donor liver transplant recipients from the CLTR, a database and official website for national data gathering. patients who met the enrollment criteria were screened for postoperative complications and survival for statistical analysis to understand the prognosis of patients and analyze the risk factors affecting their prognosis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Liver Transplantation for Hepatocellular Carcinoma Arising in Non-cirrhotic Liver: a Propensity Score-matched Retrospective Cohort Study of Two National Databases

NCT06364839

Hepatocellular Carcinoma, Non-cirrhotic Liver

COMPLETED

Rapid Assessment of Donor Liver Quality

NCT03647059

Transplant; Failure, Liver

UNKNOWN

Predicting Response to Systemic Therapies for Hepatocellular Carcinoma(HCC)

NCT05543304

Hepatocellular Carcinoma Non-resectable Effect of Drug

UNKNOWN

Observational Clinical Study of the Natural Course and Long-term Prognosis of Patients With Chronic Liver Disease

NCT05653830

Chronic Liver Disease

RECRUITING

HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular Carcinoma

NCT04499833

Hepatocellular Carcinoma, Scirrhous Recurrence Tumor

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Since the Chinese organ donation system was developed in 2015, donation has been the only source of organs for transplantation in China. Adult patients (age 18 or older) who underwent LT using grafts from deceased donors between January 1st, 2015, and December 31st, 2018, were retrospectively identified using the CLTR, a database and official website for national data gathering. Based on the follow-up data of elderly DCD donor liver transplant recipients from the CLTR, a database and official website for national data gathering. patients who met the enrollment criteria were screened for postoperative complications and survival for statistical analysis to understand the prognosis of patients and analyze the risk factors affecting their prognosis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Transplantation Hepatocellular Carcinoma Survival

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

1. Recipient age ≥ 18 years and \< 65 years.
2. Donor age ≥ 18 years.

Exclusion Criteria

1. Recipient age \<18 years or ≥65 years.
2. Donor age \<18 years.
3. Patients who died within 30 days after transplantation.
4. Secondary liver transplantation.
5. Multiple organ transplantation.
6. Patients with incomplete data or failed follow-up.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No